Abel Hall LLC’s GE HealthCare GEHC Stock Holding History

Abel Hall LLC’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,873	Closed	-$236K	–	876
2025 Q4	$236K	Buy	+2,873	New	+$224K	0.06%	461

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Abel Hall LLC's GEHC Position: Q1 2026 in Review

Abel Hall LLC sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,873 shares — an estimated $236K sold.

Abel Hall LLC first reported a position in GEHC in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Abel Hall LLC reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 2,873 GE HealthCare shares in Q1 2026, an estimated $236K.
Abel Hall LLC first reported a position in GE HealthCare in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's GE HealthCare position peaked at $236K in Q4 2025.
1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.